13 May 2024 Date | | - Cons. EPS | - EPS |
28 Feb 2024 Date | | - Cons. EPS | - EPS |
27 Nov 2023 Date | | - Cons. EPS | - EPS |
20 Nov 2023 Date | | - Cons. EPS | - EPS |
13 Nov 2023 Date | | - Cons. EPS | - EPS |
13 May 2024 Date | | - Cons. EPS | - EPS |
28 Feb 2024 Date | | - Cons. EPS | - EPS |
27 Nov 2023 Date | | - Cons. EPS | - EPS |
20 Nov 2023 Date | | - Cons. EPS | - EPS |
13 Nov 2023 Date | | - Cons. EPS | - EPS |
Medical - Diagnostics & Research Industry | Healthcare Sector | Mr. Seamus Lagan CEO | OTC PINK Exchange | 759757875 Cusip |
US Country | 96 Employees | - Last Dividend | 16 Mar 2022 Last Split | - IPO Date |